Section Arrow
EIKN.NASDAQ
- Eikon Therapeutics
Quotes are at least 15-min delayed:2026/06/29 00:59 EDT
Regular Hours
Last
 11.45
+1.6 (+16.24%)
Day High 
11.6826 
Prev. Close
9.85 
1-M High
11.37 
Volume 
3.17M 
Bid
11.13
Ask
11.55
Day Low
9.84 
Open
9.84 
1-M Low
8.01 
Market Cap 
533.27M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.36 
20-SMA 9.47 
50-SMA 10.19 
52-W High 17.4 
52-W Low 7.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.32/--
Enterprise Value
780.56M
Balance Sheet
Book Value Per Share
10.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris0.321+0.1152+55.98%-- 
ATAIAtaiBeckley Inc5.29+0.71+15.50%-- 
OCGNOcugen1.5+0.13+9.49%-- 
HUMAHumacyte0.7086+0.0886+14.29%-- 
RXRXRecursion Pharmaceuticals3.52+0.18+5.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.